Safety and efficacy of chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma with renal impairment

被引：13
|
作者：
Li, Hujun [1 ,2 ,3 ]
Yin, Lingling [1 ,2 ,3 ]
Wang, Ying [1 ,2 ,3 ]
Wang, Xiangmin [1 ,2 ,3 ]
Shi, Ming [4 ,5 ]
Cao, Jiang [1 ,2 ,3 ]
Yan, Zhiling [1 ,2 ,3 ]
Sang, Wei [1 ,2 ,3 ]
Cheng, Hai [1 ,2 ,3 ]
Zhu, Feng [1 ,2 ,3 ]
Sun, Haiying [1 ,2 ,3 ]
Li, Depeng [1 ,2 ,3 ]
Jing, Guangjun [6 ]
Zheng, Junnian [4 ,5 ]
Li, Zhenyu [1 ,2 ,3 ]
Xu, Kailin [1 ,2 ,3 ]
机构：
[1] Xuzhou Med Univ, Dept Hematol, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China
[2] Xuzhou Med Univ, Blood Dis Inst, Xuzhou, Jiangsu, Peoples R China
[3] Jiangsu Key Lab Bone Marrow Stem Cells, Xuzhou, Jiangsu, Peoples R China
[4] Xuzhou Med Univ, Ctr Clin Oncol, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China
[5] Xuzhou Med Univ, Cacer Inst, Xuzhou, Jiangsu, Peoples R China
[6] iCARTAB Biomed Co Ltd, Suzhou, Jiangsu, Peoples R China
来源：
BONE MARROW TRANSPLANTATION | 2020年 / 55卷 / 11期
基金：
中国国家自然科学基金;
关键词：
DEXAMETHASONE; MANAGEMENT; DIAGNOSIS;
D O I：
10.1038/s41409-020-0930-5
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：2215 / 2218
页数：4
相关论文
共 50 条
  • [1] Safety and efficacy of chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma with renal impairment
    Hujun Li
    Lingling Yin
    Ying Wang
    Xiangmin Wang
    Ming Shi
    Jiang Cao
    Zhiling Yan
    Wei Sang
    Hai Cheng
    Feng Zhu
    Haiying Sun
    Depeng Li
    Guangjun Jing
    Junnian Zheng
    Zhenyu Li
    Kailin Xu
    Bone Marrow Transplantation, 2020, 55 : 2215 - 2218
  • [2] Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma with renal impairment
    Sidana, Surbhi
    Peres, Lauren C.
    Hashmi, Hamza
    Hosoya, Hitomi
    Ferreri, Christopher
    Khouri, Jack
    Dima, Danai
    Atrash, Shebli
    Voorhees, Peter
    Simmons, Gary
    Sborov, Douglas W.
    Kalariya, Nilesh
    Hovanky, Vanna
    Bharadwaj, Sushma
    Miklos, David
    Wagner, Charlotte
    Kocoglu, Mehmet H.
    Kaur, Gurbakhash
    Davis, James A.
    Midha, Shonali
    Janakiram, Murali
    Freeman, Ciara
    Alsina, Melissa
    Locke, Frederick
    Gonzalez, Rebecca
    Lin, Yi
    Mcguirk, Joseph
    Afrough, Aimaz
    Shune, Leyla
    Patel, Krina K.
    Hansen, Doris K.
    HAEMATOLOGICA, 2024, 109 (03) : 777 - 786
  • [3] Efficacy and Safety of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Immunoglobulin D Multiple Myeloma
    Chen, Wei
    Wang, Ying
    Qi, Kunming
    Shi, Ming
    Cao, Jiang
    Bhansali, Rahul
    Wang, Xue
    Liu, Yang
    Li, Hujun
    Zhang, Huanxin
    Yan, Zhiling
    Sang, Wei
    Cheng, Hai
    Zhu, Feng
    Sun, Haiying
    Li, Depeng
    Jing, Guangjun
    Zheng, Junnian
    Li, Zhenyu
    Xu, Kailin
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (03): : 273.e1 - 273.e5
  • [4] Current advances in chimeric antigen receptor T-cell therapy for refractory/relapsed multiple myeloma
    Huang, He
    uW, Heng-wei
    Hu, Yong-xian
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2020, 21 (01): : 29 - 41
  • [5] Prognostic impact of corticosteroid and tocilizumab use on the efficacy of chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma
    Costa, Bruno
    Flynn, Jessica
    Nath, Karthik
    Nishimura, Noriko
    Devlin, Sean
    Farzana, Tasmin
    Chung, David
    Landau, Heather
    Lahoud, Oscar
    Scordo, Michael
    Shah, Gunjan
    Hassoun, Hani
    Maclachlan, Kylee
    Hultcrantz, Malin
    Korde, Neha
    Lesokhin, Alexander
    Shah, Urvi
    Tan, Carlyn Rose
    Giralt, Sergio
    Usmani, Saad
    Mailankody, Sham
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S36 - S36
  • [6] Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: A Real-World Experience
    Lal, Bhavesh Mohan
    Pandey, Toshali
    Alzubi, Marah
    Alrawabdeh, Jawad
    Shaughnessy Jr, John D.
    Zhan, Fenghuang
    Siegel, Eric
    Schinke, Carolina
    Thanendrarajan, Sharmilan
    Zangari, Maurizio
    van Rhee, Frits
    Al Hadidi, Samer
    BLOOD, 2024, 144 : 2405 - 2406
  • [7] Idecabtagene Vicleucel Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma with Renal Insufficiency: Real World Experience
    Sidana, Surbhi
    Peres, Lauren C.
    Hashmi, Hamza
    Hosoya, Hitomi
    Ferreri, Christopher J.
    Atrash, Shebli
    Khouri, Jack
    Voorhees, Peter M.
    Dima, Danai
    Simmons, Gary
    Kalariya, Nilesh
    Hovanky, Vanna
    Bharadwaj, Sushma
    Arai, Sally
    Miklos, David B.
    Wagner, Charlotte B.
    Davis, James
    Sborov, Douglas W.
    Nishihori, Taiga
    Alsina, Melissa
    Locke, Frederick L.
    Gonzalez, Rebecca
    Kocoglu, M. Hakan
    Sannareddy, Aishwarya
    Afrough, Aimaz
    McGuirk, Joseph P.
    Shune, Leyla O.
    Patel, Krina
    Hansen, Doris K.
    BLOOD, 2022, 140 : 10377 - 10379
  • [8] Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma
    Hosen, Naoki
    CANCERS, 2019, 11 (12)
  • [9] Chimeric antigen receptor T-cell therapy for multiple myeloma
    Wang, Zehua
    Chen, Chen
    Wang, Lei
    Jia, Yongxu
    Qin, Yanru
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [10] Chimeric antigen receptor T-cell therapy for multiple myeloma
    Hosen, Naoki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (04) : 530 - 534
12345